Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,455,013.90

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$34.92

▼ -0.91 (-2.54%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780
3/17/2023	Jack Anders	CFO	Sell	665	$21.78	$14,483.70	55,233
3/17/2023	Margaret A. Horn	Insider	Sell	1,230	$21.78	$26,789.40	100,062
3/10/2023	Thilo Schroeder	Director	Buy	100,000	$20.46	$2,046,000.00	1,553,134
3/7/2023	Thilo Schroeder	Director	Buy	550,000	$22.00	$12,100,000.00	1,453,134
12/19/2022	Jack Anders	CFO	Sell	658	$22.94	$15,094.52	29,298
12/19/2022	Xiaolin Wang	Insider	Sell	708	$22.94	$16,241.52	30,527
10/31/2022	Margaret A. Horn	COO	Sell	17,767	$20.41	$362,624.47	17,767
10/26/2022	Margaret A. Horn	Insider	Sell	17,768	$20.15	$358,025.20	35,534
9/19/2022	Jack Anders	CFO	Sell	449	$19.04	$8,548.96	29,956
9/19/2022	Xiaolin Wang	Insider	Sell	735	$19.04	$13,994.40	31,235
7/22/2022	Lorence H. Kim	Director	Buy	50,000	$20.00	$1,000,000.00	60,500
6/17/2022	Xiaolin Wang	Insider	Sell	665	$17.75	$11,803.75	31,970
6/8/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	419,901	$20.25	$8,502,995.25	5,104,130
3/28/2022	Thilo Schroeder	Director	Buy	725	$24.71	$17,914.75
3/25/2022	Thilo Schroeder	Director	Buy	42,000	$24.79	$1,041,180.00
3/23/2022	Thilo Schroeder	Director	Buy	53,118	$23.72	$1,259,958.96
3/21/2022	Thilo Schroeder	Director	Buy	75,731	$20.74	$1,570,660.94
3/18/2022	Thilo Schroeder	Director	Buy	82,200	$20.30	$1,668,660.00
3/17/2022	Margaret A. Horn	Insider	Sell	321	$18.61	$5,973.81
3/11/2022	Thilo Schroeder	Director	Buy	3,110	$20.93	$65,092.30
3/9/2022	Thilo Schroeder	Director	Buy	39,600	$20.07	$794,772.00
3/7/2022	Thilo Schroeder	Director	Buy	103,005	$18.39	$1,894,261.95
3/4/2022	Thilo Schroeder	Director	Buy	56,300	$17.69	$995,947.00
3/2/2022	Thilo Schroeder	Director	Buy	116,290	$18.94	$2,202,532.60
2/18/2022	Thilo Schroeder	Director	Buy	400,000	$17.00	$6,800,000.00
2/8/2022	Thilo Schroeder	Director	Buy	300,000	$45.00	$13,500,000.00
12/17/2021	Jack Anders	Insider	Sell	170	$24.41	$4,149.70
9/17/2021	Jack Anders	Insider	Sell	166	$30.02	$4,983.32
6/17/2021	Xiaolin Wang	Insider	Sell	243	$34.12	$8,291.16
6/3/2021	Rock Ventures Ii L.P. Third	Major Shareholder	Sell	378,117	$30.20	$11,419,133.40
5/25/2021	Rock Ventures Ii L.P. Third	Major Shareholder	Sell	135,000	$30.93	$4,175,550.00
4/28/2021	Peter Svennilson	Director	Sell	100	$42.50	$4,250.00	20,302
4/26/2021	Peter Svennilson	Director	Sell	52,984	$42.85	$2,270,364.40	20,302

The only accurate crypto trading system I know …

From Weiss Ratings | Ad

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

Here's what our expert says you should buy before April 14.

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Allspring Global Investments Holdings LLC	3,218	$0.10M	0.0%	N/A	0.002%
4/4/2024	Mass General Brigham Inc	338,191	$10.90M	19.1%	N/A	0.205%
3/11/2024	Vanguard Group Inc.	14,634,391	$419.71M	0.0%	+51.8%	8.886%
3/5/2024	Mubadala Investment Co PJSC	278,000	$7.97M	0.0%	N/A	0.169%
3/5/2024	Wellington Management Group LLP	14,882,086	$426.82M	0.1%	+40.8%	9.036%
3/1/2024	Goldman Sachs Group Inc.	1,053,257	$30.21M	0.0%	+67.9%	0.961%
2/28/2024	American International Group Inc.	71,494	$2.05M	0.0%	+41.3%	0.065%
2/26/2024	Perceptive Advisors LLC	818,882	$23.49M	0.5%	-38.0%	0.747%
2/16/2024	Price T Rowe Associates Inc. MD	4,636,353	$132.97M	0.0%	-9.0%	4.231%
2/15/2024	Virtus ETF Advisers LLC	3,540	$0.10M	0.1%	-9.6%	0.003%
2/15/2024	Legal & General Group Plc	108,682	$3.12M	0.0%	+42.2%	0.099%
2/15/2024	Barclays PLC	353,785	$10.15M	0.0%	+54.7%	0.323%
2/15/2024	Vanguard Group Inc.	14,634,391	$419.71M	0.0%	+51.8%	13.356%
2/15/2024	Voya Investment Management LLC	175,349	$5.03M	0.0%	+333.6%	0.160%
2/15/2024	Wolverine Trading LLC	20,151	$0.58M	0.0%	N/A	0.018%
2/15/2024	Nextech Invest Ltd.	6,296,740	$180.59M	33.6%	+30.1%	5.747%
2/15/2024	Nuveen Asset Management LLC	384,668	$11.03M	0.0%	+39.9%	0.351%
2/15/2024	Price T Rowe Associates Inc. MD	4,636,353	$132.97M	0.0%	-9.0%	4.231%
2/15/2024	Profund Advisors LLC	61,107	$1.75M	0.1%	+55.1%	0.056%
2/15/2024	BVF Inc. IL	5,981,212	$171.54M	4.3%	+50.2%	5.459%
2/15/2024	Boxer Capital LLC	4,279,464	$122.74M	6.1%	-8.6%	3.906%
2/14/2024	Royal Bank of Canada	45,563	$1.31M	0.0%	+205.8%	0.042%
2/14/2024	Avidity Partners Management LP	60,000	$1.72M	0.1%	-90.9%	0.055%
2/14/2024	Bellevue Group AG	5,091,000	$146.01M	2.2%	+7.8%	4.646%
2/14/2024	Balyasny Asset Management L.P.	567,105	$16.27M	0.0%	-31.1%	0.518%
2/14/2024	Shell Asset Management Co.	1,871	$54K	0.0%	N/A	0.002%
2/14/2024	Pale Fire Capital SE	11,142	$0.32M	0.0%	N/A	0.010%
2/14/2024	Vestal Point Capital LP	725,000	$20.79M	2.2%	N/A	0.662%
2/14/2024	Sectoral Asset Management Inc.	13,710	$0.39M	0.2%	-90.4%	0.013%
2/13/2024	Bain Capital Life Sciences Investors LLC	1,112,396	$31.90M	3.1%	N/A	1.015%
2/13/2024	Northern Trust Corp	1,270,795	$36.45M	0.0%	+36.2%	1.160%
2/13/2024	American International Group Inc.	71,494	$2.05M	0.0%	+41.3%	0.065%
2/13/2024	Public Employees Retirement Association of Colorado	13,686	$0.39M	0.0%	-83.1%	0.012%
2/13/2024	Tower Research Capital LLC TRC	8,545	$0.25M	0.0%	-58.7%	0.008%
2/13/2024	First Trust Advisors LP	61,554	$1.77M	0.0%	-28.5%	0.056%
2/13/2024	Goldman Sachs Group Inc.	1,053,257	$30.21M	0.0%	+67.9%	0.961%
2/13/2024	Rafferty Asset Management LLC	365,095	$10.47M	0.0%	+60.9%	0.333%
2/13/2024	NEOS Investment Management LLC	10,904	$0.31M	0.0%	N/A	0.010%
2/13/2024	The Manufacturers Life Insurance Company	178,987	$5.13M	0.0%	+15.1%	0.163%
2/13/2024	Finepoint Capital LP	617,100	$17.70M	5.0%	+44.5%	0.563%
2/13/2024	KBC Group NV	2,261	$65K	0.0%	N/A	0.002%
2/13/2024	California State Teachers Retirement System	114,105	$3.27M	0.0%	+29.4%	0.104%
2/9/2024	US Bancorp DE	2,259	$65K	0.0%	+63.1%	0.002%
2/9/2024	UBS Group AG	306,558	$8.79M	0.0%	+215.5%	0.280%
2/9/2024	Norges Bank	281,705	$8.08M	0.0%	N/A	0.257%
2/8/2024	Manchester Capital Management LLC	2,782	$80K	0.0%	N/A	0.003%
2/7/2024	Principal Financial Group Inc.	30,194	$0.87M	0.0%	+22.8%	0.028%
2/7/2024	Dimensional Fund Advisors LP	1,795,421	$51.50M	0.0%	+8.0%	1.639%
2/7/2024	Teacher Retirement System of Texas	23,375	$0.67M	0.0%	+10.6%	0.021%
2/7/2024	E Fund Management Co. Ltd.	19,532	$0.56M	0.0%	+67.6%	0.018%
2/6/2024	Charles Schwab Investment Management Inc.	1,042,967	$29.91M	0.0%	+36.0%	0.952%
2/6/2024	Amalgamated Bank	18,495	$0.53M	0.0%	+18.7%	0.017%
2/6/2024	Los Angeles Capital Management LLC	8,801	$0.25M	0.0%	N/A	0.008%
2/6/2024	Swiss National Bank	200,131	$5.74M	0.0%	+22.3%	0.183%
2/5/2024	Victory Capital Management Inc.	558,369	$16.01M	0.0%	+63.1%	0.510%
2/2/2024	State of New Jersey Common Pension Fund D	113,390	$3.25M	0.0%	+51.1%	0.103%
2/1/2024	New York State Common Retirement Fund	60,842	$1.75M	0.0%	+43.9%	0.056%
2/1/2024	Handelsbanken Fonder AB	40,175	$1.15M	0.0%	+182.9%	0.037%
1/31/2024	Beaumont Financial Advisors LLC	14,924	$0.43M	0.0%	N/A	0.014%
1/31/2024	Xponance Inc.	8,728	$0.25M	0.0%	N/A	0.008%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	19,818	$0.57M	0.0%	+18.8%	0.018%
1/30/2024	Mackenzie Financial Corp	8,652	$0.25M	0.0%	N/A	0.008%
1/30/2024	Strs Ohio	9,700	$0.28M	0.0%	+54.0%	0.009%
1/25/2024	Nisa Investment Advisors LLC	2,431	$70K	0.0%	-22.9%	0.002%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	80,405	$2.31M	0.0%	+45.5%	0.073%
1/24/2024	Arizona State Retirement System	28,384	$0.81M	0.0%	+34.0%	0.026%
1/24/2024	China Universal Asset Management Co. Ltd.	18,941	$0.54M	0.1%	+576.0%	0.017%
1/18/2024	Clear Harbor Asset Management LLC	7,200	$0.21M	0.0%	N/A	0.007%
1/12/2024	SG Americas Securities LLC	3,595	$0.10M	0.0%	-93.8%	0.003%
1/9/2024	Wedmont Private Capital	49,600	$1.46M	0.1%	N/A	0.045%
1/5/2024	Exchange Traded Concepts LLC	11,282	$0.32M	0.0%	+242.4%	0.010%
12/18/2023	Vanguard Group Inc.	9,643,591	$266.94M	0.0%	+3.2%	8.801%
12/7/2023	Hudson Bay Capital Management LP	43,095	$1.19M	0.0%	-82.2%	0.039%
12/6/2023	Citigroup Inc.	97,234	$2.69M	0.0%	-20.6%	0.089%
12/1/2023	Wellington Management Group LLP	10,572,475	$292.65M	0.1%	+2.7%	9.649%
11/24/2023	Deutsche Bank AG	53,001	$1.47M	0.0%	+13.7%	0.048%
11/21/2023	Walleye Trading LLC	7,321	$0.20M	0.0%	N/A	0.007%
11/21/2023	Walleye Capital LLC	95,517	$2.64M	0.0%	N/A	0.087%
11/16/2023	Morgan Stanley	801,973	$22.20M	0.0%	-18.5%	0.732%
11/15/2023	The Manufacturers Life Insurance Company	155,536	$4.31M	0.0%	+13.3%	0.142%
11/15/2023	Royal Bank of Canada	14,899	$0.41M	0.0%	+75.4%	0.014%
11/15/2023	Rock Springs Capital Management LP	725,152	$20.07M	0.5%	+3.2%	0.662%
11/15/2023	Sectoral Asset Management Inc.	142,650	$3.95M	0.8%	N/A	0.130%
11/15/2023	Seven Eight Capital LP	44,247	$1.23M	0.1%	+375.6%	0.040%
11/15/2023	Kennedy Capital Management LLC	10,662	$0.30M	0.0%	-27.1%	0.010%
11/15/2023	Legal & General Group Plc	76,447	$2.12M	0.0%	+2.1%	0.070%
11/15/2023	Adage Capital Partners GP L.L.C.	30,000	$0.83M	0.0%	N/A	0.027%
11/15/2023	Ameriprise Financial Inc.	1,211,856	$33.54M	0.0%	-1.0%	1.106%
11/15/2023	AQR Capital Management LLC	9,601	$0.27M	0.0%	N/A	0.009%
11/14/2023	Fred Alger Management LLC	4,542	$0.13M	0.0%	N/A	0.004%
11/14/2023	Avidity Partners Management LP	657,200	$18.19M	0.7%	-38.9%	0.600%
11/14/2023	California State Teachers Retirement System	88,156	$2.44M	0.0%	-11.1%	0.080%
11/14/2023	Tower Research Capital LLC TRC	20,691	$0.57M	0.0%	+602.6%	0.019%
11/14/2023	Qube Research & Technologies Ltd	218,432	$6.05M	0.0%	N/A	0.199%
11/14/2023	Profund Advisors LLC	39,396	$1.09M	0.1%	-34.0%	0.036%
11/13/2023	Column Group LLC	1,230,641	$34.06M	22.6%	-52.2%	1.123%
11/13/2023	Northern Trust Corp	933,125	$25.83M	0.0%	+1.7%	0.852%
11/13/2023	Federated Hermes Inc.	4,547	$0.13M	0.0%	N/A	0.004%
11/13/2023	Aigen Investment Management LP	21,071	$0.58M	0.1%	N/A	0.019%
11/13/2023	Invesco Ltd.	205,402	$5.69M	0.0%	+189.8%	0.187%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $34.92

$34.23

$36.37

50 Day Range

MA: $31.70

$29.00

$37.41

52 Week Range

Now: $34.92

$15.44

$38.73

Volume

1,243,721 shs

Average Volume

1,250,504 shs

Market Capitalization

$5.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Rock Ventures Iii LP Third (Major Shareholder)
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Margaret A Horn (Insider)
Lorence H Kim (Director)
Jeff Cislini (General Counsel)
Xiaolin Wang (Insider)
Barbara Weber (Director)
Sushil Patel (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Mass General Brigham Inc — 0.21%
Allspring Global Investments Holdings LLC — 0.00%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: During the last quarter, RVMD stock was purchased by institutional investors including:
Mass General Brigham Inc
Allspring Global Investments Holdings LLC
In the last year, these company insiders have bought Revolution Medicines stock:
Rock Ventures Iii LP Third (Major Shareholder)
Thilo Schroeder (Director)
Learn More investors buying Revolution Medicines stock.

Your Money is Not Safe

From American Alternative | Ad

CLICK HERE TO GET YOUR GUIDE NOW